2009 Midyear New-Build Update: Pharmaceutical-Biotech Industry Completes Construction of 40 North American Facilities

2009 Midyear New-Build Update: Pharmaceutical-Biotech Industry Completes Construction of 40 North American Facilities

2009 Midyear New-Build Update: Pharmaceutical-Biotech Industry Completes Construction of 40 North American Facilities


Attachment: IIR Chart - New Pharma and Biotech Plants

SUGAR LAND--June 24, 2009--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--The first six months of one of the toughest years in recent history are almost over. A recent analysis of new builds for the North American Pharmaceutical-Biotech Industry has revealed some surprisingly positive news in the form of 40 new manufacturing plants and research centers. Every market region has enjoyed the addition of at least one new site becoming operational during the first six months of this year.

Other companies featured: Bristol-Myers Squibb Company's (NYSE:BMY), Laboratory Corporation of America (NYSE:LH)

Subscribe Now!(All Fields Required)

Standard Membership - Free